Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ASE Technology Holding Co Ltd (ASX) vs AstraZeneca plc (AZN) Price & Performance

ASE Technology Holding Co LtdTrade
AstraZeneca plcTrade

Price performance (Past 24H)

Key statistics

ASE Technology Holding Co Ltd vs AstraZeneca plc — how do they compare? ASE Technology Holding Co Ltd trades at $40.33 (market cap $92.88B), while AstraZeneca plc trades at $170.44 (market cap $262.75B). The key difference: AstraZeneca plc is far larger — about 2.8× ASE Technology Holding Co Ltd's market cap, and AstraZeneca plc pays the higher dividend (1.84%). Which is the better fit depends on your goals.

ASXAZN
Market Cap
$92.88B$262.75B
Sector
TechnologyHealth
52-Week High
$45.12$209.48
52-Week Low
$9.50$137.44
Enterprise Value
$97.32B$289.00B
Dividend Yield
0.98%1.84%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ASE Technology Holding Co Ltd

ASE Technology Holding Co Ltd is a semiconductor assembly and testing firm. The company operates in segments: Packaging, Testing, and Electronic Manufacturing Services. Of these, packaging services contribute the most revenue. It involves packaging bare semiconductors into completed semiconductors with improved electrical and thermal characteristics. The Testing Segment includes front-end engineering testing, wafer probing, and final testing services. In the EMS segment, the company designs manufacture and sells electronic components and telecommunication equipment motherboards. The company is based in Taiwan but garners over half its sales from firms in the United States.

Read more on ASX

About AstraZeneca plc

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Read more on AZN